Disability Benefits for Leukemia

How SSA Evaluates Leukemia Under Listing 13.06

SSA evaluates leukemia under Blue Book listing 13.06, with rules that differ by type:

• Acute leukemia — including acute lymphoblastic leukemia (ALL) and acute myelogenous leukemia (AML) — is considered disabling for at least 24 months from the date of diagnosis or relapse, whichever is later. A pathology report confirming the diagnosis is enough; you do not need to prove anything else. Acute leukemia is also on SSA's Compassionate Allowances list, so the claim is fast-tracked.
• Chronic myelogenous leukemia (CML) in the accelerated or blast phase is considered disabling for at least 24 months from the date that phase was documented. CML in the chronic phase, which many people manage with daily tyrosine kinase inhibitor pills, does not automatically meet the listing and is evaluated based on its actual effects.
• Chronic lymphocytic leukemia (CLL) is generally evaluated under the lymphoma criteria of listing 13.05 or based on its complications — severe anemia, recurrent infections, or the need for aggressive treatment.
• Stem cell or bone marrow transplant for any leukemia means SSA considers you disabled for at least 12 months from the transplant date (24 months for acute leukemia), and lasting complications such as graft-versus-host disease are evaluated afterward.

After the Guaranteed Period

When the 24-month period for acute leukemia ends, benefits do not automatically stop. SSA reviews your condition and considers remission status, ongoing maintenance chemotherapy, fatigue, infection risk, and any organ damage from treatment before deciding whether you can return to work.

Medical Evidence SSA Needs for a Leukemia Claim

Leukemia claims are usually documented through laboratory and pathology evidence. SSA will look for:

• Bone marrow biopsy and pathology reports confirming the diagnosis and the leukemia type — this single document can satisfy the listing for acute leukemia.
• Complete blood counts and peripheral blood smears showing blast percentages, anemia, and platelet levels over time.
• Cytogenetic and molecular testing, such as the Philadelphia chromosome (BCR-ABL) for CML, which also documents which phase the disease is in.
• Treatment records — induction and consolidation chemotherapy, targeted therapy, hospitalizations for infections or transfusions, and transplant records with dates.
• Documentation of relapse, if any, because relapse restarts the 24-month disability period for acute leukemia.

For chronic leukemia that does not meet a listing outright, records showing recurrent infections, transfusion dependence, severe fatigue, and hospitalizations become the heart of the claim, so make sure every episode is reflected in your medical file.

Qualifying Without Meeting the Leukemia Listing

Chronic-phase CML and early-stage CLL often do not meet listing 13.06, but many people with these conditions still qualify through a residual functional capacity (RFC) assessment. Daily targeted therapy can cause persistent fatigue, muscle cramps, nausea, and fluid retention. CLL commonly brings recurrent infections that force time off work, along with anemia that limits exertion and drenching night sweats that disrupt sleep and daytime concentration.

An RFC built on these limitations — reduced exertional capacity, the need to avoid workplaces with infection exposure, extra breaks for fatigue, and expected absences during infection flares — can rule out past work. The medical-vocational grid rules then direct a finding of disabled for many claimants age 50 and older limited to sedentary work, or 55 and older limited to light work. Documented absences of two or more days per month for illness or treatment are often enough by themselves to rule out all competitive employment.

Tips for a Stronger Leukemia Claim

Keep these points in mind when applying:

• For acute leukemia, apply immediately and submit the pathology report. The diagnosis alone qualifies you for at least 24 months, and Compassionate Allowances processing can approve the claim in weeks.
• Know your CML phase. If your records document accelerated or blast phase, highlight that language — it meets the listing.
• Track infections and hospital stays. For CLL, a pattern of recurrent serious infections is often the strongest evidence.
• Report medication side effects at every visit so fatigue and other effects of daily therapy are documented, not just assumed.
• Calendar your review date. Benefits for acute leukemia are guaranteed for 24 months, and gathering evidence of ongoing limitations before SSA's review helps benefits continue if you still cannot work.